Bisheng Cheng

机构：Beth Israel Deaconess Medical Center, Harvard University, Nanfang Hospital, University of Hong Kong - Shenzhen Hospital, Southern Medical University, University of Hong Kong · ORCID：0009-0005-2300-3583

发表论文 44 篇 · 总被引 563 次 · h-index 12

代表论文

• Role of tertiary lymphoid structures in the tumour microenvironment and immunotherapy response of renal cell carcinoma (2025 · Clinical and Translational Medicine · 被引 7)
• Induction of ferroptosis in prostate cancer by CCDC719-13 via TRIM21-mediated ubiquitination of SLC7A11 (2025 · Cell Death and Differentiation · 被引 7)
• Urinary exosomal FAM153C-RPL19 chimeric RNA as a diagnostic and prognostic biomarker for prostate cancer in Chinese patients (2025 · Cancer Letters · 被引 6)
• Profiling chimeric RNA in prostate cancer in Chinese cohorts reveals similarities and differences compared to Western populations (2025 · iMeta · 被引 6)
• FomA‐Containing Outer Membrane Vesicles of Fusobacterium Nucleatum Facilitate Bladder Cancer Lymphatic Metastasis via IL‐6‐Dependent M2b Macrophage Polarization (2026 · Advanced Science · 被引 4)
• Antibody–Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions (2026 · MedComm · 被引 3)